Healthcare Integrated (HITC) Form 5 Healthcare Integrated / Susan Raymundo Reyes ownership change

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0362
Estimated average burden
hours per response:	1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Form 3 Holdings Reported.

X

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

Reyes Susan Raymundo

(Last) (First) (Middle)

743 FOX LANDING LANE

(Street)

KNOXVILLE TN 37922

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Healthcare Integrated Technologies Inc. [ HITC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
Chief Medical Officer

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
07/31/2024

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
				Amount	(A) or (D)	Price
Common Stock	07/31/2023		A4(1)	1,516,666	A	$0.11	1,516,666	D
Common Stock	07/31/2024		A4(2)	258,360	A	$0.1	258,360	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
					(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Holdings	$0.4			3(3)			09/01/2020	09/01/2025	Common Stock	150,000		150,000	D
Holdings	$0.4			3(3)			09/01/2021	09/01/2025	Common Stock	283,333		283,333	D
Holdings	$0.4			3(3)			09/01/2022	09/01/2025	Common Stock	283,333		283,333	D
Holdings	$0.4			3(3)			09/01/2023	09/01/2025	Common Stock	283,334		283,334	D

Explanation of Responses:

1. On July 31, 2023, the Board of Directors of the issuer approved the issuance of 1,516,666 shares of common stock to the Reporting Person as payment for compensation owed to her as of July 31, 2023 under her Employment Agreement dated September 1, 2020.

2. On July 31, 2024, the Board of Directors of the issuer approved the issuance of 258,360 shares of common stock to the Reporting Person as payment for compensation owed to her as of July 31, 2024 under her Employment Agreement dated January 31, 2024.

3. On September 1, 2020, the Reporting Person was appointed Chief Medical Officer of the issuer. Upon execution of an Employment Agreement dated on such date, the Reporting Person was awarded 1,000,000 common stock purchase options, all of which are currently vested.

	/s/ Susan R. Reyes	08/07/2024
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.